Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-18

Clinical Trial Update: Mycophenolate Mofetil Plus Steroid in the Treatment Of Patients With Progressive Idiopathic Membranous Nephropathy [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating mycophenolate mofetil plus steroids for progressive idiopathic membranous nephropathy is underway, with unclear status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Idiopathic Membranous Nephropathy | Phase 4 | Status: UNKNOWN